Delivery Order SPE2DR25D6029-SPE2DR26FXP6V
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Multihance 529mg/ml. The delivery order, valued at $5,323.05, has a firm fixed price and an ultimate completion date of March 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,659.26, is a Delivery Order that covers the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,208.48, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts, including a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,175.30 to AmerisourceBergen Drug Corp for the supply of Gadavist 1 mmol/ml bulk vials (30ml). This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a $4,057.92 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price contract, with completion targeted for September 10, 2025, represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $2,503.35 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), carries no set-aside designation and is scheduled...
- The Defense Logistics Agency awarded a $2,809.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 mL vials, a gadolinium-based contrast agent used in magnetic resonance imaging procedures. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, was competitively awarded without set-aside provisions and is scheduled for completion by September 3, 2025. AmerisourceBergen,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,207.99 to AmerisourceBergen Drug Corp for Triescence 40 mg/ml vials, a pharmaceutical product for military and federal healthcare use. This non-competitive delivery order, issued on August 11, 2025, with completion by August 12, 2025, operates under firm fixed pricing and represents a small-value transaction within the company's broader federal medical supply portfolio. The performance location is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Omnipaque 180 mg/mL vials (10 mL units) with a ceiling value of $1,003.30. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- This delivery order for $302 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation for PROHANCE 279.3 MG/ML VIAL 15ML. The contract has a firm fixed price and period of performance through September 2023. To be delivered by the prime contractor, Amerisourcebergen Drug Corporation, operating from its corporate office location in Conshohocken, Pennsylvania, the contrast agent will support the Defense Logistics Agency's medical supply chain objectives. No set-aside...